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Inflammation is associated with depressive symptoms and innate immune mechanisms are likely causal in some cases of major
depression. Systemic inflammation also perturbs brain function and microstructure, though how these are related remains unclear.
We recruited N= 46 healthy controls, and N= 83 depressed cases stratified by CRP (> 3mg/L: N= 33; < 3mg/L: N= 50). All
completed clinical assessment, venous blood sampling for C-reactive protein (CRP) assay, and brain magnetic resonance imaging
(MRI). Micro-structural MRI parameters including proton density (PD), a measure of tissue water content, were measured at 360
cortical and 16 subcortical regions. Resting-state fMRI time series were correlated to estimate functional connectivity between
individual regions, as well as the sum of connectivity (weighted degree) of each region. Multiple tests for regional analysis were
controlled by the false discovery rate (FDR= 5%). We found that CRP was significantly associated with PD in precuneus, posterior
cingulate cortex (pC/pCC) and medial prefrontal cortex (mPFC); and with functional connectivity between pC/pCC, mPFC and
hippocampus. Depression was associated with reduced weighted degree of pC/pCC, mPFC, and other nodes of the default mode
network (DMN). Thus CRP-related increases in proton density—a plausible marker of extracellular oedema—and changes in
functional connectivity were anatomically co-localised with DMN nodes that also demonstrated significantly reduced hubness in
depression. We suggest that effects of peripheral inflammation on DMN node micro-structure and connectivity may mediate
inflammatory effects on depression.
Molecular Psychiatry; https://doi.org/10.1038/s41380-021-01272-1
INTRODUCTION
Depression and inflammation are strongly co-associated. Cohorts
of patients with depression have increased blood concentrations
of C-reactive protein (CRP) and pro-inflammatory cytokines
compared to healthy controls. Patients with systemic inflamma-
tory disease have increased incidence of “co-morbid” depressive
symptoms [1, 2]. Longitudinal epidemiological studies [3–6],
clinical studies of depression induced by interferon- treatment
for hepatitis [7], and experimental studies of animal models of
depression and sickness behaviour [8], collectively provide
evidence that inflammation can precede and could cause
depression.
Some of the clearest evidence that peripheral inflammation can
cause changes in the human brain has come from functional
magnetic resonance imaging (fMRI) studies of emotional or
cognitive task-related activation. Experimental studies have
collected fMRI data before and after controlled administration of
a safe inflammatory challenge, e.g., typhoid vaccination of healthy
volunteers, so that any before-after differences in brain function
can be considered causal effects of peripheral inflammation [9].
Observational studies [10, 11] have reported correlations between
task-related activation and experimentally uncontrolled between-
subject variation in CRP or other peripheral immune biomarkers.
Meta-analysis of 24 experimental and observational studies (total
N~457) demonstrated replicable and significant effects of
inflammation on task-related activation in dorsal anterior cingu-
late cortex (dACC), subgenual anterior cingulate cortex (sgACC)
and adjacent areas of medial prefrontal cortex (mPFC), insula,
hippocampus, amygdala, and striatum [12].
Functional MRI has also been used to investigate the relation-
ship between peripheral inflammation and functional connectiv-
ity, usually measured by the correlation between resting-state
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fMRI time series at a pair of brain regions. Seed-based correlational
analyses, typically focused on a few a priori regions of interest and
discrete features of depression, have shown that typhoid
vaccination-induced increases in interleukin-6 (IL6, a pro-
inflammatory cytokine) were negatively correlated with mood-
associated changes in functional connectivity of the sgACC in
healthy volunteers [9]. In depressed patients, CRP has been shown
to negatively correlate with the functional connectivity of both the
striatum and amygdala to mPFC, which mediate specific
depressive features of anhedonia and anxiety, respectively
[13, 14]. More recently, studies using whole brain (connectomic)
analysis have reported IL6-related changes in connectivity of
sgACC and mPFC [15], lipopolysaccharide-induced (LPS) increases
in cortico-subcortical connectivity [16], IFN-induced decreases in
cortico-subcortical connectivity[17], and an internally replicated
association between peripheral inflammation (indexed by a
composite measure of CRP, IL6, and other cytokines) and reduced
connectivity of an emotion regulation network [18]. Finally, a
functional MRI sub-set of the data presented here was analysed
using a complementary, whole-brain network based approach,
which also showed widespread connectivity reduction with
increased CRP [19]. However, task-related or resting-state fMRI is
fundamentally limited as a marker of inflammation-related brain
changes due to its lack of cellular or molecular specificity.
Micro-structural MRI is a complementary, though less-
commonly used, approach to imaging effects of inflammation
on the human brain. In contrast to more traditional macro-
structural parameters, e.g., cortical thickness, which combine data
from multiple voxels to measure brain anatomy, micro-structural
MRI parameters represent the composition of brain tissue within
each voxel. For example, magnetization transfer (MT) is a micro-
structural MRI technique for measuring parameters which are
biophysically interpretable in terms of the relative proportions of
bound versus free water protons, or absolute proton density (PD).
Experimental inflammatory challenges in healthy volunteers have
induced significant changes in MT parameters in the striatum and
other structures [20–22]. Clinical studies of patients with brain
disorders with a known neuroinflammatory component, such as
multiple sclerosis and stroke, have reported significantly increased
PD, which has been interpreted as a marker of increased
extracellular fluid volume, i.e., oedema, of brain tissue [23, 24].
Here we combined whole brain fMRI measurements of
functional connectivity with MT measurements of micro-
structure in an effort to elucidate how inflammation-related
differences in the local, biophysical properties of brain tissue could
be related to more distributed changes in functional connectivity
between cortical and subcortical nodes of depression-related
brain networks. CRP was used to stratify cases prospectively
because it is measurable by a reliable, high sensitivity assay with a
well-defined cut-off value for defining low grade systemic
inflammation. Functional connectivity and micro-structural para-
meters were measured in the same set of 360 cortical areas and
16 subcortical regions in a sample of depressed cases (N= 83,
including 33 with CRP > 3mg/L) and healthy controls (N= 46). On
this basis, we tested three principal hypotheses: (i) there are
inflammation-related differences in quantitative MT parameters of
brain tissue composition; (ii) there are inflammation-related
differences in functional connectivity of cortico-subcortical net-
works; and (iii) inflammation-related differences in micro-structure
and functional connectivity are anatomically co-located with each
other and with depression-related changes in functional con-
nectivity of cortico-subcortical networks.
METHODS AND MATERIALS
Study design and sample
Depression cases were ascertained as those participants who screened
positive for current depressive symptoms on the Structured Clinical
Interview for DSM-5 (SCID) screening questionnaire [25], scored >13 on the
Hamilton Rating Scale for Depression [HAM-D]; [26] on two occasions (once
at enrolment and again immediately prior to scanning), and screened
negative for bipolar disorder or non-affective psychosis. The study was
designed to be inclusive of some aspects of heterogeneity, including
treatment resistance. Healthy controls screened negative for past or
current depressive disorder on the SCID screening questionnaire. All
participants satisfied additional inclusion and exclusion criteria (listed
completely in Supplementary Information (SI) Table S1). In particular, to
minimise the potentially cofounding effects of any systemic disorders that
were likely to compromise the interpretation of immunological data, major
medical disorders including type I and type II diabetes, severe
cardiovascular disorders e.g., stroke, MI, and BMI ≥ 36 kg/m2, were all
exclusionary. All procedures were approved by an independent national
research ethics service (NRES) committee (NRES: East of England,
Cambridge Central, UK; Reference: 15/EE/0092). All participants provided
written informed consent and received up to £325 reimbursement.
We collected complete data from 143 eligible participants who were
recruited into three a-priori groups: healthy controls with CRP < 3mg/L
(HC, N= 53), depressed cases with CRP < 3mg/L (loCRP cases, N= 55), and
depressed cases with CRP > 3mg/L (hiCRP cases, N= 35). All groups were
matched for mean age, sex and handedness. Subject to quality control
criteria applied to MRI and other data, the final, evaluable dataset is
summarised in Results, Table 1 and SI Fig. S1.
Structural MRI data acquisition and pre-processing. Quantitative magneti-
zation transfer (qMT) images were acquired using a magnetization transfer-
weighted spoiled gradient echo sequence (voxel size 2.4 × 2.4 × 2.5 mm).
The data were realigned and the following parameters estimated per
voxel: proton density (PD), bound proton fraction (fb), MT exchange rate
(kbf), and the transverse relaxation times of the bound and free water
components (T2b, T2f). In order to account for differences in overall
scanner sensitivity, we divided regional PD values by mean PD per subject,
resulting in PD measurements globally normalized to unity. These maps
were then regionally parcellated into 360 cortical regions, defined a priori
using a well-validated parcellation template [27], and 8 subcortical regions
defined bilaterally by the FreeSurfer atlas [28, 29]: thalamus, caudate,
putamen, pallidum, hippocampus, amygdala, accumbens, and ventral
diencephalon. This resulted in a 376-length vector for each of 5 regional
qMT parameters for each participant.
fMRI data acquisition and pre-processing
We used a multi-echo echoplanar imaging (EPI) sequence [30] to collect
resting state fMRI data with the following parameters: TR= 2.57 s; total
acquisition time = 10mins 42.5 s= 250 time points; voxel size: 3.75mm×
3.75mm× 3.99mm (for one site these parameters were marginally
different, see SI page 4)
The first 6 volume were disregarded (for magnetization equilibration)
then data were pre-processed using multi-echo independent component
analysis (ME-ICA; [31, 32]) to identify sources of variance in the fMRI time
series that scaled linearly with TE and could thus be confidently regarded
as BOLD signal. Other non-BOLD sources of variance, such as head
movement, that do not scale with TE, were identified by ME-ICA and
discarded. The retained independent components yielded a denoised fMRI
time series at each voxel which was bandpass filtered using the Maximal
Overlap Discrete Wavelet Transform resulting in a BOLD signal oscillating
in the frequency range 0.01–0.1 Hz (wavelet scales 2–4). For each
participant, mean framewise displacement (FD) was calculated by
averaging the FD time series. Scans for three participants were excluded
due to high in-scanner motion, defined by prior quality control criteria of
<FD>RMS > 0.3 mm or max(FD) > 1.3 mm, and one other scan was excluded
due to high mean correlation (r > 0.7) between all regional fMRI time series,
which was considered to reflect systemic imaging artefacts.
Each pre-processed fMRI image was regionally parcellated into the same
set of cortical and subcortical regions as the qMT data and the regional
mean fMRI time series estimated for each cortical and sub-cortical region.
Thus we estimated a 376 × 244 regional time series matrix for each
participant. The functional connectivity between each regional pair of fMRI
time series was estimated by Pearson’s correlation coefficient r for each
possible pair of regions, resulting in a 376 × 376 symmetric association or
functional connectivity matrix. Weighted degree of each node was
calculated as the corresponding row (or column) mean of this matrix
[33]. This sample is similar, but not identical, to the fMRI-only sample
drawn from the same study for complementary analysis of functional
connectivity [19].
















We adopted a hierarchical approach, proceeding from global through
regional (nodal) to edge-wise scales of analysis. First, we used Kolmogorov-
Smirnov tests to assess between-group differences in whole brain
distributions of regional microstructural measures and functional con-
nectivity (edge weights between each pair of regions). Significant group
differences at the whole brain level were then further investigated for all
376 brain regions, with linear associations between CRP and microstruc-
tural measures or weighted degree estimated by regression for each
regional node. Finally, linear association between CRP and functional
connectivity was estimated by regression for each of 70,500 edges in the
whole brain connectome and for each of the 375 edges connecting each
subcortical structure to all other nodes. All mass univariate significance
tests of between-group differences in MRI metrics, and associations
between CRP and MRI metrics, were controlled for multiple comparisons
by the false discovery rate (PFDR < 0.05).
RESULTS
Sample
Socio-demographic and clinical data are summarised in Table 1 for
the sample with analysable fMRI data. Healthy controls were
group mean-matched to all depressed cases on age and sex. As
anticipated, there were significant case-control differences in
depression, anxiety, fatigue, and anhedonia scores, as well as
retrospectively self-reported childhood adversity exposure, with
mean HAM-D scores falling in the moderate severity range.
Depressed cases with high CRP included a higher proportion of
women (85%) and had higher BMI (29) than cases with low CRP
(58% female, BMI= 26). There were no significant differences
between high and low CRP subgroups of cases in terms of
clinician- or self-rated depression severity, state or trait anxiety,
fatigue or anhedonia scores. Likewise, Within the group of cases,
there were no significant correlations between CRP and any of
these questionnaire measures of depressive psychopathology; see
Fig. S15.
MT scans were excluded from one assessment centre (KCL)
because of technical incompatibility with MT data from the other
two centres (Oxford and Cambridge; see Fig. S14). Consequently,
the sample size for micro-structural analysis is smaller (Table S2)
than for fMRI analysis Table 1.
Proton density: between-group differences and correlation
with CRP
We estimated the global brain distribution of each MT parameter,
across all 360 cortical and 16 sub-cortical regions for all groups.
This demonstrated a highly significant difference in the distribu-
tion of PD (right-shifted) in high CRP (> 3mg/L) versus low CRP
(< 3mg/L) depression cases (Kolmogorov-Smirnov test, P < 6.4 ×
10−7) and between high CRP depresssed cases and controls
(Fig. 1A). After controlling for multiple comparisons, there were no
equivalent between-group differences for the global distributions
of the other MT parameters (kbf, fb, T2b, T1f, T2f; see SI Fig. S2 and
Table S3), so these were not further analysed.
Therefore, we next tested between-group differences in PD at
each of 376 brain regions, controlling for multiple comparisons
with PFDR < 0.05. There were no significant differences between
controls and all depressed cases (Fig. 1B). Taken together with the
convergent distributional results in global PD, these regional data
indicated that there was not a major effect of depression on PD.
Therefore, we proceeded to investigate the association between
PD and CRP using data from all participants (cases and controls
combined).
We regressed PD on CRP at each region, resulting in a
parcellated map of the association between PD and CRP, denoted
PD~CRP (Fig. 1C, D). Proton density positively correlated with CRP
in 22 regions with PFDR < 0.05. This included 10 regions of
posterior cingulate cortex and precuneus (pC/PC; RSC, PCV, 7 m,
POS1, v23ab, d23ab, 31pv, 31pd, 31a, ProS), 6 regions of inferior,
orbital and polar frontal cortex (IFJa, IFSa, a10p, p10p, p47r, OFC), 2
regions of anterior cingulate and medial prefrontal cortex (pOFC,
25), and single regions of dorsolateral prefrontal, premotor,
paracentral and ventral visual stream cortex (9a, 6r, 5 m and
VMV1, respectively). PD scaled negatively with CRP in 7 regions of
Table 1. Socio-demographic and clinical data on the analysable sample from this case-control study of depression cases, stratified by high or low
CRP, and healthy controls.
Controls Cases p loCRP Cases hiCRP Cases p
n 46 83 50 33
Sex (female/male) 27/19 57/26 0.335 29/21 28/5 0.015
Age, years 35.5 (7.5) 37.1 (7.3) 0.244 36.8 (7.1) 37.6 (7.6) 0.631
Body mass index 24.5 (4.2) 26.8 (4.1) 0.002 25.6 (3.7) 28.8 (3.9) <0.001
C-reactive protein, mg/L 0.9 (0.7) 2.9 (2.9) <0.001 1.0 (0.7) 5.8 (2.6) <0.001
Clinician-rated depressiona 0.5 (0.9) 19.3 (5.2) <0.001 19.4 (5.4) 19.2 (4.9) 0.846
Self-rated depressionb 2.0 (2.8) 25.3 (8.8) <0.001 24.7 (8.4) 26.2 (9.4) 0.445
State anxietyc 26.9 (7.8) 51.2 (10.7) <0.001 51.2 (10.8) 51.1 (10.7) 0.957
Trait anxiety 29.4 (5.9) 60.6 (9.2) <0.001 60.3 (9.7) 60.9 (8.6) 0.767
Fatigued 10.7 (2.5) 20.5 (5.7) <0.001 20.4 (5.6) 20.6 (5.8) 0.866
Anhedoniae 0.2 (0.6) 5.0 (3.6) <0.001 5.3 (3.4) 4.7 (3.8) 0.484
Childhood traumaf 38.2 (5.1) 53.2 (14.2) <0.001 55.8 (14.9) 49.2 (12.3) 0.039
Treatment resistant – 50 – 28 (56%) 22 (67%) 0.367
Number of antidepressants – 2.7 (1.7) – 2.6 (1.5) 2.9 (2.0) 0.405
aHAMD-17: Hamilton Rating Scale for Depression [51], a 17-item clinician-administered rating scale for reliable assessment of symptoms in patients diagnosed
with depression, with a total score range 0–52.
bBDI: Beck Depression Inventory version 2 [52], a 21-item self-report questionnaire, with a total score range 0–63.
cSTAI: Spielberger State-Trait Anxiety Rating Scale [53], a 40-item self-report measure of trait and state anxiety.[stai]
dCFS: Chalder Fatigue Scale [54], a 14-item self-report instrument to measure the severity of fatigue in adults.
eSHAPS: Snaith-Hamilton Pleasure Scale [55], a 14-item self-report measure of anhedonia (loss of the normal capacity for pleasurable experience), one of two
principal symptoms of depression.
fCTQ: Childhood Trauma Questionnaire [56], a standardized, retrospective 28-item self-report inventory that measures the severity of five classes of childhood
trauma: emotional abuse, physical abuse, sexual abuse, emotional neglect, and physical neglect.
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prefrontal and premotor cortex. (See Table S4 for anatomical
details).
Functional connectivity: depression-related differences
We plotted the distributions of all pair-wise fMRI time series
correlations (70,500) on average over all participants in each (sub)
group (Fig. 2A, left). Distributions were generally positive, but
differed significantly between cases and controls (Kolmogorov-
Smirnov [KS] test, P < 2.2 × 10−16). Depressed cases had a
functional connectivity distribution left-shifted compared to
controls, indicating a greater proportion of negatively weighted
functional connections, especially in the high CRP subgroup.
We also plotted the distribution of all nodal measures of weighted
degree (i.e., connectivity of each region to all other regions) on
average over all participants in each (sub)group (Fig. 2A, right).
Weighted degree was always positive in the range 0.07–0.42 but, in
depressed cases, the degree distribution was significantly left-
shifted, indicating fewer hub nodes with high degree and more non-
hub nodes with near-zero degree (KS, P < 2.2 × 10–16). Within the
group of depressed cases, the degree distribution was left-shifted in
high CRP versus low CRP subgroups (KS, P < 5 × 10−5).
To localise these case-control differences in functional con-
nectivity, we estimated the mean inter-areal correlation matrix for
each group Fig. 2B. These functional connectomes had a block-
diagonal appearance, representing the modular community
structure of the networks, for both groups. Regions in the same
modules were generally positively correlated with each other. In
contrast, there were strong negative correlations between the
default mode network (DMN) and the ventral attention (VA) and
dorsal attention (DA) modules, especially in depressed cases
compared to controls (see Fig. S7 for an alternative approach
using ICA components instead of the pre-defined Yeo networks).
We used weighted degree as a measure of hubness of cortical
node in the functional connectome (Fig. 2C). Depression was
associated with significantly reduced hubness (i.e., global con-
nectivity) of 39 regions of pC/pCC, inferior parietal cortex, mPFC
and hippocampus (PFDR < 0.05; Table S4), many of which were
affiliated to the DMN (Fig. 2C). More formally, the mean degree of
all nodes within the DMN was significantly reduced for depressed
cases compared to controls; and there were no significant case-
control differences of modular degree for any other prior modules
(Fig. 2D, Fig. S3).
Functional connectivity: correlation with CRP and mediation
analysis
In light of the significant depression-related differences in
functional connectivity, we next estimated the association
between CRP and functional connectivity using data from all
depressed cases (excluding controls).
Following our hierarchical analysis plan, we finally regressed
CRP on each of 70,500 pair-wise inter-regional correlations to
assess inflammation-related changes in functional connectivity at
the most fine-grained scale of the connectome, i.e., individual
edges rather than regional nodal degrees or global correlation
distributions. Three regional pair-wise connections scaled posi-
tively with CRP (PFDR < 0.05), two between DMN nodes (pc/pCC
areas: v23ab to RSC, and POS1 to hippocampus), and one between
the hippocampus and mPFC (area 10r). One connection scaled
negatively with CRP, between area 7Pm (adjacent to pC/pCC) and
the frontal-opercular area, FOP1 (Fig. 3A). At more lenient FDR
thresholds more negative edges started to appear. Specifically at
PFDR < 0.1 we see two connections between the PCC (areas d23ab
and 31pv) and the dorsal ACC (area a32pr) whose strength scales
negatively with CRP.
Fig. 1 Proton density MRI: association with CRP. A Densities of normalized group mean PD over 376 regions for all cases, all controls, and for
high CRP and low CRP subgroups of cases. B From left to right, cortical maps of: PD for all controls, PD for all cases, case-control difference in
PD (t -statistic), and no significant case-control differences in PD with PFDR < 0.05. C Left, cortical t -statistic map of association between
regional PD and blood CRP concentration, PD~CRP, in all cases and controls combined; right, map of regions where PD~CRP was significantly
greater than zero (orange regions), or less than zero (blue regions), with regional PFDR < 0.05. D Left, scatterplot of PD (y-axis) versus CRP
(x-axis) for posterior cingulate cortical region v23ab; right, scatterplot of PD versus CRP for dorsolateral prefrontal cortical region, p47r.
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Given the involvement of the hippocampus in two of the three
connections that positively scaled with CRP, we used seed-based
correlational analysis to investigate the association between CRP
and the functional connectivity of the hippocampus with each of
the other 187 regions per hemisphere. This showed that high CRP
was associated with increased functional connectivity between
the hippocampus and 3 other regions located in the pC/pCC and
mPFC (Fig. 4A, C; see Table S5 for details of CRP-related changes in
connectivity of hippocampus, putamen and thalamus). We
explored the associations between functional connectivity of each
of these edges and participants’ psychopathology scores including
anxiety and anhedonia; however, none of these associations were
statistically significant after controlling for multiple comparisons,
see Fig. S16 for details.
Notably, some of the cortical areas, e.g., POS1, v23ab, where
functional connectivity scaled significantly with CRP also demon-
strated a significant association between PD and CRP (Fig 4B; but
not depression, cf. Figures S10–11). This co-localisation (Fig. S8) of
inflammation-related effects on brain micro-structure and func-
tional connectivity could represent either a direct effect of CRP on
both PD and functional connectivity, or an indirect (mediated)
effect of CRP on functional connectivity via its direct effect on PD
(or vice-versa). We used mediation analysis to evaluate these
models for two specific examples of structural/functional co-
localisation of CRP-related effects: (1) CRP scaled positively with
PD in the pC/pCC area POS1, and scaled positively with functional
connectivity between POS1 and hippocampus. Here, mediation
analysis indicated a direct effect of CRP on hippocampal
connectivity. (2) CRP scaled positively with PD in pc/PCC areas
d23ab and 31pv, and scaled negatively with functional connectiv-
ity between d23ab/31pv and mPFC area a32pr. Here, mediation
analysis indicated that the association of CRP with medial
prefrontal connectivity was mediated by its direct effect on PD
in posterior cingulate cortex.
DISCUSSION
We tested the prior hypotheses that peripheral inflammation is
associated with disruptions in human brain micro-structure and
functional connectivity that co-locate with depression-related
changes in functional networks. Our results supported these
predictions and generated new hypotheses about how peripheral
inflammation may perturb brain structure and function, and their
role in depression.
Inflammation-related changes in proton density
The clearest signal of inflammation-related change was provided
by the micro-structural MRI measurements of proton density (PD)
at global (Fig. 1A) and regional scales of analysis (Fig. 1C). We
found 22 areas of association cortex, particularly within the DMN,
Fig. 2 Functional connectivity: depression-related differences. A Left, group mean distributions of pair-wise correlation or functional
connectivity for all controls, all cases, and high or low CRP subgroups of cases. Right, group mean distribution of weighted degree or nodal
hubness for all controls, all cases, and high or low CRP subgroups of cases. Insets show the same data on a log scale to clarify between-group
differences in the negative (or less positive) tails of the distributions. B Group mean functional connectivity matrices for all controls (left) and
all cases (right). Each row or column in these symmetrical matrices represents one of 360 cortical regions which have been ordered by their
prior affiliation to resting state networks or modules [57]: VIS= visual, MOT=motor, DA= dorsal attentional, VA= ventral attentional, LIM=
limbic, FP= fronto-parietal, DMN= default mode network. In total, 16 subcortical regions are designated SUB. C Cortical and subcortical maps
of group mean weighted degree for controls and cases, and the map of significant case-control differences in weighted degree (PFDR < 0.05).
In both groups, high degree hub nodes were concentrated in somatosensorimotor, visual and auditory cortices; low degree non-hub nodes
were concentrated in DMN cortical areas and subcortical structures. There was significantly reduced hubness of nodes in many cortical areas
of the default mode network (DMN, right column). D Boxplots of weighted degree of all cortical nodes in the DMN for all controls, all cases,
and high or low CRP subgroups of cases. ** denotes significant between-group differences in modular degree of DMN (P < 0.05).
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where PD scaled positively (pC/PCC and mPFC) or to a lesser
extent negatively (DLPFC) with CRP. These results were robust to
multiple comparisons correction at PFDR < 0.05 and to sensitivity
analyses including correction for potentially confounding variables
(sex, BMI, childhood adversity CTQ, total number of antidepres-
sants, whether currently on antidepressants, as well as Global
Signal Regression) and restriction to data from depressed cases
only (Fig. S4).
Proton density measures the concentration of MRI-visible
protons. In the brain, most protons are in water, and PD is
typically interpreted as a measure of tissue-free water content
[34]. In clinical studies of stroke, glioma, multiple sclerosis (MS)
and hepatic encephalopathy [23, 24, 35, 36] increased PD has
typically been interpreted as a marker of increased extracellular
fluid volume, or oedema [35, 37]. Convergently, animal experi-
ments have shown that peripheral inflammation can cause
increased free water in brain tissue measured directly by a
gravimetric technique [38].
Thus, an intuitive interpretation of our finding that CRP was
associated with increased PD in pC/PCC and mPFC is that low-
grade systemic inflammation is associated with localised oedema
of these components of the DMN. This accords with studies
reporting acute reductions in brain volume (interpreted as a
reduction in hydration and extracellular fluid volume) after
initiation of potent immunosuppressive therapies in multiple
sclerosis, the so-called “pseudoatrophy phenomenon” [39].
However, analogous to our finding of regions showing a negative
scaling of PD with CRP, some prior studies have also reported
regional increases in brain volume (interpreted as an increase in
hydration and extracellular fluid volume) following anti-
inflammatory therapies [40]. Thus there is prior evidence, compatible
with our findings, that variation in systemic inflammation can cause
both localised increases and decreases in the water composition of
brain tissue. Further studies, ideally translating between MRI studies
of animals and humans, will be needed to validate the biophysical
interpretation of inflammation-related changes in PD, to clarify the
regional specificity of brain water associations with peripheral pro-
or anti-inflammatory states [40], and to understand why PD is
apparently more sensitive to the effects of systemic inflammation on
brain tissue composition than other micro-structural MRI markers of
free water content, such as MT or T1 [41].
Depression-related changes in functional connectivity
The clearest signal of depression-related change was provided by
fMRI measurements of functional connectivity, at global (Fig. 2A,
B) and regional scales of analysis (Fig. 2C, Table S4). We found that
39 cortical areas and the hippocampus had significantly attenu-
ated hubness, or degree of connectivity to the rest of the
connectome, of which 27 (69%) were affiliated to the DMN. These
results were robust to several sensitivity analyses including
correction for BMI, head movement, and other potentially
confounding variables (Fig. S4).
Fig. 3 Functional connectivity: correlation with CRP and mediation analysis. A Cortical maps highlighting edges between regional nodes
defined by significant correlation of functional connectivity with CRP (FDR corrected at 0.05 and 0.1). B Mediation analysis of the direct effect
of CRP on PD in posterior cingulate cortical area POS1, the direct effect of CRP on functional connectivity between POS1 and hippocampus
(represented by the red edge between nodes in the brain map), and the effect of PD on POS1-hippocampal connectivity. The direct effects of
CRP on POS1 PD and hippocampal connectivity are significant but there is no indirect effect of CRP on hippocampal connectivity mediated by
its effect on PD in posterior cingulate cortex. C Mediation analysis of the direct effect of CRP on PD in posterior cingulate cortical areas d23ab
and 31pv, the direct effect of CRP on functional connectivity between d23ab/31pv and medial frontal area a32pr (represented by the blue
edge between nodes in the brain map), and the effect of PD on d23ab/31pv-hippocampal connectivity. The direct effect of CRP on d23ab/
31pv PD and there is an indirect effect of CRP on medial prefrontal connectivity mediated by its effect on PD in posterior cingulate cortex.
(ACME: average causal mediation effect, ADE: average direct effect).
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Depression-related abnormalities of task-related activation and
functional connectivity of sgACC, pC/PCC and other nodes of the
DMN have been extensively reported [42–44]. Increased con-
nectivity between DMN nodes, but decreased connectivity
between DMN and non-DMN nodes, has been conceived as an
imbalance between task-negative (DMN) and task-positive (non-
DMN) systems that underpins cognitive biases in depression
[45, 46]. Meta-analyses have highlighted the importance of
dysconnectivity between the pC/pCC and the ventral attention
and frontoparietal networks for the emergence of ruminative
thoughts and emotional dysregulation characteristic of depression
[47]. Our finding of reduced degree of functional connectivity of
39 DMN areas is compatible with depression-related disconnec-
tion of the DMN from wider task positive areas.
Mechanistic interpretation
One pathogenic hypothesis generated by these data is that the
posterior DMN is particularly susceptible to localised increase in
extracellular water, induced by peripheral inflammation, and
indexed by PD. We used CRP as a convenient, well-established
proxy for peripheral innate immune system activation; but we
don’t assume that CRP itself traverses or signals across the blood
brain barrier (BBB). Instead, it seems more likely that high CRP
serves as a surrogate for increased blood concentrations of pro-
inflammatory cytokines or myeloid immune cells which can
traverse the BBB to exert effects on inflammation-responsive
brain regions [48]. Whatever the precise mechanism of peripheral
immune signalling to the pC/pCC, this region is central to
the regulation of information flow throughout the DMN, via
connections to the hippocampus and mPFC [44]. Thus
inflammation-induced oedema of pC/PCC could perturb the
functional connectivity between nodes within the DMN, and/or
between DMN and non-DMN nodes, ultimately causing changes
in emotion and cognition diagnosed clinically as depression [45].
We found preliminary evidence that localised inflammatory
effects on posterior cingulate cortex micro-structure could
mediate indirect effects of inflammation on some functional
connections of the putatively edematous areas. However,
causality cannot be inferred from our current cross-sectional
study and further translational and longitudinal MRI studies will
clearly be needed to investigate this mechanistic model linking
inflammatory effects on cortical micro-structure to dysconnec-
tivity of depression-related functional networks.
Methodological issues and limitations
The sample size is not large so there is a risk of inadequate power to
detect small effects of depression or inflammation in sub-group
analyses of the control group alone (see Figs. S12 and S13). Future
studies of non-depressed control groups with unrestricted variation in
CRP, e.g., the UK Biobank sample, will be required to clarify the
relationship between functional connectivity and high CRP in the
absence of depressive symptoms. Relatedly, serious medical disorders
(including type I and type II diabetes, severe cardiovascular disorders
and BMI ≥ 36 kg/m2) were exclusionary to avoid compromising
interpretation of immunological data. It will therefore be important to
determine the generalizability of our findings to depressed popula-
tions with higher levels of obesity or medical co-morbidity. The
depressed cases (but not controls) were enriched for patients with
CRP > 3mg/L, potentially confounding depression- and inflammation-
related effects on MRI markers. However, this risk was mitigated by
Fig. 4 Hippocampal connectivity: correlation with CRP. A Top row, brain maps of t-statistics representing strength of association between
CRP and functional connectivity of the hippocampus (with each of the other brain regions). Bottom row, cortical maps highlighting regions
where CRP was significantly, positively correlated with functional connectivity with the hippocampus (PFDR < 0.05). B Scatterplots illustrating
the relationship between CRP and hippocampus connectivity for two cortical regions: POS1 and v23ab. Bottom, scatterplots of CRP versus PD
for the same cortical regions; * denotes P < 0.05. C Voxel based analysis of functional connectivity dependence on CRP for a seed in the PCC
(top row) and for a seed in the right Hippocampus (bottom row). Functional connectivity between hippocampus, PCC, and mPFC was
positively correlated with CRP (only significant clusters with α < 0.05 are shown; global significance threshold P < 0.05).
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robustness of key results to sensitivity analyses of data from cases
only. In the principal analysis, we controlled for age and scanning
centre; but not for effects of sex, BMI and childhood adversity, given
prior evidence that all of these factors are risk factors for both
depression and inflammation. However, key results were conserved
after statistical correction for BMI and childhood adversity, and
analysis of female-only data (Figs. S5 and S6). Sensitivity analyses
controlling for anti-depressant drug treatment-resistance included as
a covariate the total number of previous episodes of anti-depressant
treatment with different drugs (Table 1, Fig. S4). Head movement
during scanning is a well-recognised source of bias in fMRI
connectivity analysis. We used a well-validated pre-processing
pipeline for movement correction and all data passed standard
quality control criteria for head movement before statistical analysis
(see Fig. S9). Nonetheless, we used global signal regression [49] as an
alternative pre-processing strategy for motion correction in sensitivity
analyses that demonstrated conservation of our key results (Fig. S4).
Finally, a number of studies have demonstrated scaling of CRP
and/or IL6 with specific phenotypic dimensions of depression (such
as anhedonia, psychomotor slowing, or anxiety). Some of these
dimensions of depressive psychopathology have also been linked to
inflammation-related changes in mPFC connectivity to ventral and
dorsal striatum, and amygdala [13, 14, 50]. It is therefore noteworthy
that we also observed significant CRP-related changes in mPFC
functional connectivity. However, we did not observe significant
associations between CRP and scores on questionnaire measures of
depressive symptom severity, anxiety, anhedonia or fatigue in this
group of depressed cases (Fig. S15). Perhaps unsurprisingly in this
context, there was also no evidence for significant association
between any of these questionnaire scores and the strength of
functional connections that were significantly correlated with CRP
(Fig. S16). Conceptually, it seems likely that inflammation-related
changes in functional connectivity should be related to specific
dimensions of depressive psychopathology. More refined investiga-
tion of this concept is warranted as an important focus for future
fMRI connectivity studies using larger samples of depressed cases
with more comprehensive phenotyping of both psychopathological
or cognitive phenotypes and peripheral immune profiles.
CODE AVAILABILITY
The analysis packages used in this study are freely available through the following
links:Structural analysis and registration: https://freesurfer.net Micro-structural
analysis of qMT data: https://github.com/spinicist/QUIT Functional analysis of resting
state multi-echo fMRI data: https://github.com/manfredg/MEICA-BMU.
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